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129Xe Chemical Shift in Human Blood and Pulmonary
Blood Oxygenation Measurement in Humans Using
Hyperpolarized 129Xe NMR
Graham Norquay,1 General Leung,1 Neil J. Stewart,1 Jan Wolber,1,2 and Jim M. Wild1*
Purpose: To evaluate the dependency of the 129Xe-red blood
cell (RBC) chemical shift on blood oxygenation, and to use
this relation for noninvasive measurement of pulmonary blood
oxygenation in vivo with hyperpolarized 129Xe NMR.
Methods: Hyperpolarized 129Xe was equilibrated with blood
samples of varying oxygenation in vitro, and NMR was performed
at 1.5 T and 3 T. Dynamic in vivo NMR during breath hold apnea
was performed at 3 T on two healthy volunteers following inhala-
tion of hyperpolarized 129Xe.
Results: The 129Xe chemical shift in RBCs was found to increase
nonlinearly with blood oxygenation at 1.5 T and 3 T. During breath
hold apnea, the 129Xe chemical shift in RBCs exhibited a periodic
time modulation and showed a net decrease in chemical shift of
1 ppm over a 35 s breath hold, corresponding to a decrease of
7–10 % in RBC oxygenation. The 129Xe-RBC signal amplitude
showed a modulation with the same frequency as the 129Xe-RBC
chemical shift.
Conclusion: The feasibility of using the 129Xe-RBC chemical shift
to measure pulmonary blood oxygenation in vivo has been dem-
onstrated. Correlation between 129Xe-RBC signal and 129Xe-RBC
chemical shift modulations in the lung warrants further investiga-
tion, with the aim to better quantify temporal blood oxygenation
changes in the cardiopulmonary vascular circuit. Magn Reson
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INTRODUCTION
Knowledge of tissue oxygenation can provide valuable
insight into the pathophysiology of a spectrum of diseases.
For example, in the discrimination of the penumbra follow-
ing stroke (1) or identification of ischemia following myo-
cardial infarction (2). Furthermore, hypoxia limits the
efficacy of radiotherapy in the treatment of tumors (3). In
lung diseases such as asthma and chronic obstructive pul-
monary disease, hypoxia can influence the lifetime and the
functionality of neutrophils that are associated with inflam-
mation in the lungs (4). Surface blood oxygenation can be
measured with an infrared finger probe, but this approach
is depth-limited. The accepted gold standard method of
determining deep tissue oxygenation is with polarographic
electrodes, as pioneered in the late 1950s (5). This invasive
method, however, samples only a small amount of tissue
and is able to provide assessment of oxygenation for only
limited tissue volumes. Owing to this limitation, oxygen-
ation is usually estimated using surrogate techniques, such
as the monitoring of mixed venous oxygenation, heart rate,
blood pressure, and oxygen saturation at the jugular bulb.
However, these estimates can prove inaccurate as distal tis-
sue oxygenation is not necessarily well represented by the
more proximal measurements, and vice versa (6).
MR perfusion imaging can be used to measure blood
delivery to a tissue of interest, however, oxygen supply
and demand can be independent of one another, e.g.,
revascularization of fibrotic tissue provides blood flow
out of proportion to metabolic demand. Likewise, tissues
with low levels of perfusion have an adequate oxygen
supply while at rest, but an inadequate oxygen supply
during periods of increased metabolic demand. Tissue
perfusion alone, therefore, does not completely describe
the underlying physiology of gas exchange (7) and thus
direct, noninvasive measurement of blood oxygenation
may be of interest in many clinical settings, as well as
being of interest from a physiological perspective.
Several techniques have been developed to quantify
regional oxygenation using MRI. A promising method is the
use of blood oxygen level dependent (BOLD) MRI (8,9),
where images that indicate impaired oxygen uptake can be
generated, for example by cycling oxygen and carbogen
levels (10). However, this technique provides only relative
estimates of tissue oxygen partial pressure (11) because
there are endogenous variations in magnetization relaxation
parameters that can confound these measurements and
thus make absolute oxygen concentration detection diffi-
cult. Moreover, BOLD signal response is governed by a mix-
ture of T2 dephasing and diffusion due to microscopic
susceptibility gradients, and is therefore very much
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dependent upon the means of measurement, for example
the choice of pulse sequence and field strength. Techniques
that introduce exogenous tracers for MR oximetry, such as
Overhauser-enhanced MRI of unpaired radicals (12,13) and
19F MRI (14), are promising for measurement of blood oxy-
genation; however, these tracers have yet to be applied in
humans. In the lungs, the T1 of inhaled hyperpolarized
3He
gas in the airspaces (15,16) has been used to quantify
regional alveolar oxygen concentration, but regional
ventilation-perfusion mismatch and impaired gas transfer
across the alveolar capillary interstitial barrier means this
does not necessarily reflect the capillary blood oxygenation.
Xenon has been in routine clinical use for many years
as a tracer of blood perfusion (17), and the physiological
effects of xenon gas administration are well known and
characterized (18,19). Hyperpolarized 129Xe MR has been
shown in numerous studies to be a useful noninvasive
probe of lung structure (20–22) and function (23–28). Sig-
nal can be detected at low concentrations from this exoge-
nous in vivo contrast agent, and owing to xenon’s large,
loosely bound electron cloud, 129Xe NMR is highly sensi-
tive to the xenon chemical environment: 129Xe nuclei
exhibit a marked change in resonance frequency when
dissolved in different biological fluids and tissues (29,30).
Three distinct NMR peaks are observed in vivo when
129Xe gas is inhaled into the lungs. The largest peak origi-
nates from 129Xe gas in the alveolar airspaces and the two
other peaks, centered approximately 200 ppm away from
the gas peak, have been attributed to 129Xe dissolved in
lung parenchymal tissue/blood plasma (TP) and in red
blood cells (RBCs) (31,32). Physiologically important
information about gas exchange can be derived from the
signal amplitudes and exchange kinetics of these distinct
129Xe resonances (20,33). Furthermore, the 129Xe reso-
nance frequency in RBCs was shown previously by Wolber
et al. to be sensitive to blood oxygen saturation, sO2 (34).
Mechanisms underpinning the 129Xe chemical shift
dependence on blood oxygenation are not yet fully under-
stood, and the dependence is currently thought to be due
to the conformational changes of hemoglobin as it binds
and releases oxygen molecules (34).
In the study reported here, spectra of hyperpolarized
129Xe dissolved in samples of human blood were obtained
to validate the previous in vitro work conducted at B0 5
1.5 T by Wolber et al. (34). In so doing, we determine the
relationship between the 129Xe-RBC resonance frequency
and blood oxygenation, over the full oxygenation range at
the two clinically relevant field strengths of 1.5 T and 3 T.
Using this relationship, measurements of RBC sO2 in vivo
in healthy human lungs were then derived using whole
lung NMR spectroscopy measurements of lung oxygen
desaturation during breath hold apnea. A technique for
the noninvasive dynamic detection of RBC sO2 in vivo
using hyperpolarized 129Xe is hereby demonstrated.
METHODS
Hyperpolarized 129Xe Gas Preparation
For in vitro and in vivo studies, a gas mixture of 3 % isoto-
pically enriched xenon (86 % 129Xe), 10 % nitrogen and 87
% helium was flowed through a glass cell (volume 500
cm3; temperature 373 K; total gas pressure 2 bars) on a
home-built 129Xe spin-exchange optical pumping polar-
izer (35) at a flow rate of 300 sccm (standard cubic centi-
meters per minute). Upon exiting the cell, the
hyperpolarized 129Xe was cryogenically separated in a liq-
uid nitrogen-cooled distilator and collected in its frozen
state over a time of 20 min (xenon volume  200 mL) for
in vitro samples and 60 min (xenon volume 600 mL) for
in vivo samples.
Blood Sample Preparation and Analysis
Whole blood samples were withdrawn by a clinician from
three self-consenting healthy male volunteers (two Cauca-
sian, ages 23 and 27; one Asian, age 35) by venipuncture
and transferred into lithium heparin vacuum containers
approximately 2–3 h before the start of the NMR experi-
ments. All blood samples were allowed to equilibrate to a
temperature of 20 6 2 C (the temperature at which the
scanner room is maintained). Before conducting the NMR
experiments, the xenon was first dissolved in the blood.
To ensure effective mixing, the xenon and blood were
passed through an exchange module (25,36) (Superphobic
MicroModule 0.5 X 1 G680 Contactor, Membrana, USA),
which provided an exchange surface area of 100 cm2. The
exchange module was also used to control the oxygenation
of the blood samples before they were mixed with xenon.
A clinical blood gas analyzer (Radiometer, ABL80, UK)
was used to analyze each blood sample and determine the
following physiological parameters: sO2 (fraction of hemo-
globin molecules that are fully oxygenated), pO2 (partial
pressure of O2 in whole blood), pCO2 (partial pressure of
CO2 in whole blood), HCT (fraction of red blood cells
within whole blood) and pH. Immediately after acquiring
NMR spectra as described below, approximately 0.1 mL of
blood was withdrawn directly from the NMR sample
syringe and taken to the blood gas analyzer for analysis.
Full experimental details of the xenon/oxygen dissolution
method and RBC sO2 measurement technique have been
described previously in a study reporting the T1 relaxation
behavior of 129Xe in blood (37).
In Vitro NMR Spectroscopy
A custom-built, eight-turn solenoid radiofrequency (RF)
coil of 15 mm inner diameter was used for transmission/
reception at the frequency of 129Xe dissolved in RBCs
and plasma. The gas exchange membrane was positioned
near the sensitive volume of the NMR coil to reduce the
xenon-blood transit time to the coil and, thus minimiz-
ing T1 relaxation. To calibrate the excitation flip angle, a
small sample of the hyperpolarized 129Xe-blood mixture
was placed within the active coil volume. Hard pulses of
duration 500 ls were used to acquire spectra, and from
these, the 129Xe-RBC signal decrease was fitted to (cos
a)n-1, where a is the flip angle to be calibrated and n is
the RF pulse number (37). The excitation flip angles
used were calculated to be in the range 10–15.
Spectra were acquired on both 1.5 T (GE, HDx, USA)
and 3 T (Philips, Achieva, Netherlands) MR scanners. At
both B0 field strengths, 20 pulse-acquire measurements
were made with 512 sample points, a receiver bandwidth
of 2.5 kHz and a repetition time (TR) of 500 ms. Free
induction decay data were imported into MATLAB
2 Norquay et al.
(R2011b, MathWorks, USA) for spectral analysis. Zero-
order phase corrections (on the 129Xe-RBC resonance),
followed by first-order phase corrections (to phase the
129Xe-plasma resonance, using the 129Xe-RBC resonance
as the zero frequency point) were performed on the aver-
aged raw data, and absorption spectra, Re[L], were fitted
in the chemical shift (d) domain to a linear combination
of two Lorentzians
Re½LðdÞ5Ar
1
2Cr
ðd2d0r Þ21ð12CrÞ2
1Bp
1
2Cp
ðd2d0pÞ21ð12CpÞ2
[1]
where Ar, Bp are the amplitudes of the RBC and plasma
129Xe resonances; d0r , d
0
p are the maxima of the
129Xe-RBC
and 129Xe-plasma resonances; and Cr, Cp are the full
width half maxima of the two respective peaks. Figure
1a shows an example of a fit to a typical in vitro 1.5 T
129Xe-blood spectrum.
In Vivo NMR Spectroscopy
Whole-lung spectroscopy experiments were then performed
at 3 T (Philips, Achieva, Netherlands) on two healthy male
Caucasian volunteers (24 and 28 years old). All experiments
were performed during breath hold apnea lasting 35–40 s.
A 360 ls duration 90 hard pulse centered 200 ppm
downfield from the gaseous 129Xe resonance was used for
excitation of the 129Xe dissolved in RBCs (129Xe-RBC) and
parenchymal tissue/blood plasma (129Xe-TP) using a flexi-
ble quadrature transmit/receive RF coil tuned to 35.35 MHz
(Clinical MR Solutions, USA). See Figure 2 for relative sig-
nal intensities corresponding to 129Xe-gas, 129Xe-RBC, and
129Xe-TP peaks in the lungs measured at 3 T.
Two separate pulse-acquire sequences with TRs of 100
ms (performed on the 28-year-old volunteer) and 800 ms
(performed on both volunteers) were used, and the effec-
tive flip angle excitation on the 129Xe gas peak was deter-
mined to be 2.5 (see Figure 2) for a 90 excitation of the
dissolved phase 129Xe. For the TR 5 800 ms breath hold
experiments, 2048 samples were acquired at a bandwidth
of 3 kHz, corresponding to a spectral resolution of 1.46 Hz
(0.04 ppm). To achieve a TR of 100 ms at 3 kHz band-
width, the number of samples was decreased to 128,
reducing the spectral resolution to 0.7 ppm. The spectra
were phased and fitted to a double Lorentzian using the
same method outlined in the previous section.
RESULTS
In Vitro Spectroscopy
The relationship between the chemical shift of 129Xe and
sO2 of blood was calibrated in a controlled in vitro envi-
ronment. The resonance frequency of 129Xe dissolved in
plasma was used as a reference as it was found not to
FIG. 1. a: Single-shot 129Xe-blood spectrum at 1.5 T. The measured absorption spectrum (blue line) was fitted to a linear combination of two
Lorentzians (Equation [1], solid black line) to determine peak positions. b: Example 129Xe-blood spectra acquired at 3 T. With increasing oxy-
genation, the peak associated with 129Xe dissolved in RBCs is seen to shift measurably toward a higher resonance frequency.
FIG. 2. Magnitude NMR spectrum of 129Xe acquired from the human
lungs after a hard pulse excitation centered 220 ppm away from the
gas peak (depicted here as a large peak outlined in blue). Spectral
peaks associated with parenchymal tissue/blood plasma (TP) and
RBCs are an order of magnitude smaller and have broader linewidths
(shorter T2*s) than the
129Xe-gas peak. Inset: 129Xe-gas resonance flip
angle calibration for a hard pulse centered on the 129Xe-dissolved
resonance.
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vary as a function of blood oxygenation in vitro. Increas-
ing RBC sO2 caused an increase in the resonance fre-
quency of 129Xe dissolved in RBCs. The RBC-plasma
peak separation increased from approximately 20.4 ppm,
when the blood was in a completely deoxygenated state,
to approximately 25.5 ppm when the blood was in a
fully oxygenated state.
This observed chemical shift versus sO2 behavior was
consistent at B0 magnetic field strengths of both 1.5 T
and 3 T. To quantify the change in RBC-plasma peak
separation, d, as a function of sO2, the
129Xe-RBC and
129Xe-plasma peak locations, d0r and d
0
p, were determined
by fitting the spectra to Equation [1]. Blood gas analysis
was performed immediately after acquiring the NMR
spectra to quantify the RBC sO2. The extracted peak sep-
arations are plotted as a function of sO2 in Figure 3,
where it can be observed that the chemical shift of 129Xe
in RBCs appears to be nonlinearly dependent on the
measured sO2, which is consistent with the previous
observations of Wolber et al. (34). 1.5 T and 3 T data
were fitted to a single empirical equation
dðsO2Þ5 aexpðbsO2Þ1d0 [2]
where, a and b are empirical constants and d0 is the
RBC-plasma peak separation in fully deoxygenated blood
(see Figure 3). The similarity in the measured 129Xe
chemical shift values at 1.5 T and 3 T shown in Figure
3, therefore, suggest that the relationship between the
129Xe chemical shift and RBC sO2 is independent of the
static magnetic field strength.
In Vivo Detection of Chemical Shift
To determine whether a similar shift in the resonance fre-
quency of 129Xe in RBCs could be detected in vivo as a
potential noninvasive probe for pulmonary blood oxygen-
ation, a series of NMR spectra were acquired during
breath hold apnea, which provides a simple model for
blood oxygenation change. Figure 4 shows a waterfall plot
of representative dissolved 129Xe spectra acquired as a
function of time during one such experiment. The SNR of
the spectrum at the beginning of the acquisition series
was measured to be 50, dropping to 7 after 35 s of
breath hold apnea. For these typical SNRs, it was possible
to perform good Lorentzian fits on the data, enabling
accurate peak assignment. The 129Xe resonance located at
0 ppm corresponds to the 129Xe-TP resonance and the res-
onance located downfield is from 129Xe dissolved in
RBCs. For all datasets, an initial rapid drop in the 129Xe-
RBC signal was observed, which we believe to be a result
of RF-induced depolarization of the postcapillary signal
from the 129Xe in the pulmonary veins for TRs shorter
than (TR 5 100 ms), or of the order of (TR 5 800 ms), the
RBC capillary transit time of 750 ms (38).
For TR 5 800 ms, the 129Xe-TP signal exhibited a mono-
tonic decay over the breath hold time (Figure 5a). It was
assumed that this signal decay follows the T1 of the
129Xe
gas (dominated by dipolar coupling of the nuclear spin
with paramagnetic oxygen in the lungs), which acts as a
longitudinal magnetization reservoir, replenishing the
129Xe-dissolved magnetization in between RF pulses. With
this assumption, a T1 fit (corrected for
129Xe-gas signal
decay due to off-resonance RF excitations of 2.5 on the gas
resonance, which result from the side bands of the hard RF
pulses used) was performed on the decaying 129Xe-TP sig-
nal, resulting in an approximate 129Xe-gas T1 value of 18.8
s, which is in good agreement with previously measured
129Xe-gas T1 values of  20 s (39). Although the 129Xe-RBC
signal was observed to decay with the same overall rate as
the 129Xe-TP signal, it did not decay monotonically;
instead, the signal was observed to modulate periodically
over the breath hold time (see Figure 5a).
To view this oscillatory decay behavior more clearly,
the 129Xe-RBC signal was normalized to the T1 decay of
the 129Xe-gas polarization reservoir (129Xe-RBC data were
divided pointwise by the fitted T1 curve – see Figure 5b).
For both volunteers, the 129Xe-RBC peak-to-peak signal
FIG. 3. The 129Xe-RBC chemical shift plotted against the measured
blood oxygen saturation, sO2, with the
129Xe-plasma peak as a 0
ppm reference peak. Data from the two field strengths are denoted
by black open circles (1.5 T) and blue open squares (3 T). The
black line is a fit to both the 1.5 T and 3 T data using Equation [2].
The grey triangle represents blood equilibrated with carbon monox-
ide (simulating the fully oxygenated conformation of hemoglobin).
FIG. 4. Waterfall plot of a typical time series of in vivo 129Xe-dissolved
spectra. The resonance at 0 ppm is from 129Xe dissolved in parenchy-
mal parenchymal tissue/blood plasma (TP) and the resonance down-
field is from 129Xe dissolved in RBCs. Each spectrum was acquired
using a flip angle of 90 and a TR of 800 ms. The decay in both com-
partments follows approximately the T1 relaxation (due to the pres-
ence of oxygen in the lungs and RF excitation) of the 129Xe-gas, the
magnetization reservoir that acts to replenish the 129Xe-dissolved sig-
nal between RF pulses.
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interval (i.e. modulation period) was measured to be 4–8 s
(0.125–0.25 Hz).
Whereas the 129Xe-TP resonance was observed to remain
fixed in position over the 35 s breath hold, the 129Xe-RBC
resonance chemical shift was observed to decrease by
approximately 1 ppm. The first observation of in vivo
129Xe-RBC resonance shifts with lung oxygenation was first
reported in our preliminary work (40), and these findings
have been recently confirmed by Kaushik et al. (41), who
observed a decrease in the 129Xe-RBC resonance frequency
in patients with idiopathic pulmonary fibrosis relative to
healthy normals. Here, the 129Xe-RBC chemical shift exhib-
ited a periodic modulation at the same frequency as the
129Xe-RBC signal oscillation, with a 180 phase difference
(Figs. 6a, 8). Equation [2] was used to determine sO2 values
from the measured in vivo 129Xe-RBC chemical shift val-
ues. The sO2 in both volunteers at the start of the breath
hold was measured to be 0.87, dropping to 0.80 at the
end of the 35 s breath hold (Figure 6b).
In these calculations, it was assumed that the tempera-
ture difference in vitro (20 C) and in vivo (37 C) has a
negligible effect on the 129Xe-RBC and 129Xe-TP resonan-
ces, i.e. the calibration curve in Figure 3 is valid for con-
verting the in vivo 129Xe-RBC chemical shift to
pulmonary sO2. To test the validity of this assumption,
NMR spectra of 129Xe dissolved in plasma were acquired
at 20 C and 37 C with a 129Xe gas compartment as a 0
ppm reference. No differences in the 129Xe-gas and
129Xe-plasma resonances were observed when the sample
was heated from 20 C to 37 C. Albert et al. (42) previ-
ously measured a chemical shift difference of 20 ppm
between the 129Xe-RBC and 129Xe-plasma resonances in
deoxygenated blood at a temperature of 8 C, which is in
good agreement with the chemical difference of 20.4
ppm we have observed at 20 C. We therefore assume
the 129Xe-RBC resonance is independent of temperature
over the range 20 C to 37 C. For TR 5 100 ms, both
the 129Xe-TP and 129Xe-RBC signals exhibited oscilla-
tions with an approximately constant peak-to-peak signal
interval (modulation period) of 1 s over the breath hold
duration.
FIG. 5. a: Decaying in vivo 129Xe-dissolved signal in human lungs
during breath-hold apnea. The red circles and black squares rep-
resent 129Xe in RBCs and parenchymal tissue/blood plasma (TP),
respectively. While the 129Xe-TP signal decays monotonically, the
129Xe-RBC signal does not. The black line is an exponential fit to
the decaying 129Xe-TP signal, from which a 129Xe-gas T1 was esti-
mated. b: 129Xe-RBC signal divided by the fitted exponential in
(a), expressed as a fractional change (D) in signal intensity.
FIG. 6. a: 129Xe-RBC chemical shift in human lungs in vivo over the
course of a breath hold, where a clear periodic modulation is observed.
b:Calculated blood oxygenation over the breath hold, derived from the
measured 129Xe-RBC chemical shifts using Equation [2].
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DISCUSSION
In Vitro Spectroscopy
The observation of a nonlinear dependence of 129Xe-RBC
chemical shift on sO2 has been reported in previous
work by Wolber et al. (34), where it was concluded that
bulk magnetic susceptibility differences between oxyhe-
moglobin (diamagnetic) and deoxyhemoglobin (paramag-
netic) are not responsible for the 5 ppm 129Xe-RBC
chemical shift difference between oxygenated and deoxy-
genated blood. Instead, the authors hypothesized that the
observed nonlinear relationship between blood oxygen-
ation and chemical shift is the result of an oxygen-
dependent hemoglobin affinity for xenon. To date, a total
of 12 xenon binding sites have been located in deoxyhe-
moglobin using X-ray crystallography (43). To our
knowledge, the binding sites of xenon in oxyhemoglobin
have not been reported, making a quantitative descrip-
tion of the chemical shift mechanisms responsible for
the observed nonlinear change in chemical shift with
blood of oxygenation difficult at this time. Nevertheless,
herein, we draw on the insights of Wolber et al. (34) to
further understand the mechanisms governing the
observed nonlinear relationship between the 129Xe-RBC
chemical shift and blood oxygenation.
The resonance frequency of 129Xe in a solvent solution
is determined by the local magnetic field experienced at
the nucleus, which is mediated by the screening (or
shielding) constant, r:
xobs5 cBeff [3]
Beff 5 ð12rÞB0 [4]
xobs5 cð12rÞB0 [5]
where xobs is the observed resonance frequency, c is the
gyromagnetic ratio, B0 is the applied static magnetic field
and Beff is the effective field at the nucleus. Following
the pioneering work of Buckingham et al. (44), it is
known that the screening constant, r, of a nucleus can
be expressed as the sum of the screening constant of the
individual nucleus, r0, and a term arising due to the
presence of the solvent medium, rm, thus
r5 r01rm [6]
rm5ra1re1rw1rb [7]
where ra is a contribution from molecular anisotropy
effects, re is the polar effect caused by an electric field,
rw is due to the van der Waals forces between the solute
and solvent and rb indicates the shielding arising from
bulk magnetic susceptibility effects within the solvent,
which we neglect as a significant contributor to 129Xe
chemical shift changes with blood oxygenation from the
conclusions drawn by Wolber et al. (34). For 129Xe dis-
solved in solution at 20 C and at body temperature (37
C), the anisotropic and electric field terms are zero (45),
leaving only the van der Waals shielding term.
Stephen (46) has demonstrated that the van der Waals
deshielding experienced by a nucleus within a solvent can
be expressed as 2rw5BF
2
, where F
2
is the mean square
electric field brought about by fluctuations among electrons
located on the neighboring solvent molecules and B is the
“shielding hyperpolarizability” (47), which is significant
for 129Xe, whose nucleus is surrounded by a large, easily-
deformed electron cloud. As a result of this high shielding
hyperpolarizabilty, the chemical shift of dissolved 129Xe in
a solvent is very sensitive to small differences in the disper-
sion fields acting within liquid solvents. The most com-
monly used approach to correlate solvent-induced 129Xe
chemical shifts with F
2
is to use a continuum model to
describe the solvent (48,49). Specifically, F
2
is proportional
to the square of the Bayliss-McRae function, gðnÞ (49), i.e.,
F
2 / ½gðnÞ25 ½ðn221Þ=ð2n211Þ2, where n is the index of
refraction of the solvent. The refractive indices of oxyhemo-
globin and deoxyhemoglobin have been recently measured
by Zhernovaya et al. (50), wherein no significant difference
between the refractive index of deoxygenated and oxygen-
ated hemoglobin (within the visible range of the spectrum)
was reported. We therefore conclude that the observed
129Xe-RBC chemical shift change with blood oxygenation
cannot be predicted using whole blood refractive index
measurements.
Experiments using M€ossbauer spectroscopy (51) suggest
that the electron cloud of hemoglobin is drawn toward the
highly electronegative oxygen molecule in oxyhemoglo-
bin, but is more evenly distributed in deoxyhemoglobin.
Similarly, as 129Xe forms transient van der Waals bonds
with hemoglobin, the net electron cloud of 129Xe is likely
to be drawn to the more electronegative O2 molecule in
oxyhemoglobin. This would act to increase the deshield-
ing of the 129Xe nucleus, thereby reducing rw, resulting in
an increased 129Xe-RBC resonance frequency, which is in
agreement with the observed data.
In addition to changes in the electronegativity of the
hemoglobin molecules with blood oxygenation, the
xenon-hemoglobin binding site locations may change as
the hemoglobin makes transitions between oxy- and
deoxy-conformations. As the extent of the shielding con-
stant rw is strongly dependent on the separation between a
nucleus and the molecules giving rise to fluctuating elec-
tric fields (47), changes in position would greatly alter the
magnitude of the mean square field, F
2
, experienced by
the 129Xe nucleus within the hemoglobin. Each RBC con-
tains a large number of individual hemoglobin molecules,
and the fraction of hemoglobin molecules in the oxy- and
deoxy-conformations has been measured previously in
horse hemoglobin to vary smoothly as a function of blood
oxygenation (52). The intracellular environment experi-
enced by 129Xe nuclei would thus be expected to vary
smoothly as a function of blood oxygenation, which is con-
sistent with the observation of a smooth nonlinear change
in the 129Xe-RBC resonance with blood oxygenation.
Finally, to help determine whether the underlying mecha-
nisms driving the change in 129Xe relaxation rate and 129Xe-
RBC chemical shift with sO2 are related, a correlation plot of
the variation of the two NMR parameters was generated, as
shown in Figure 7. The 129Xe-RBC relaxation rate data are
taken from our previous study (37) in which the relationship
between 129Xe-RBC relaxation rate and sO2 was determined.
The plot reveals that changes in 129Xe-RBC relaxation rate
and 129Xe-RBC chemical shift are well correlated, with a
coefficient of determination of R2 5 0.83. This presents
strong empirical evidence that the underlying physical
mechanism driving these observed changes in chemical
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shift and relaxation rate is the same. As the chemical shift
and relaxation rate of 129Xe in solvents is strongly depend-
ent on intermolecular separations, we therefore conclude it
is likely that oxygen-modulated xenon binding is largely
responsible for the observed 129Xe-RBC chemical shift and
relaxation rate sO2 dependencies.
In Vivo Spectroscopy
As shown in Figures 8a and b, for TR 5 800 ms, the sO2
values calculated from the 129Xe-RBC chemical shift
were shown to oscillate over the breath hold at the same
frequency as the 129Xe-RBC signal amplitude modula-
tion, but with a 180 phase difference; the sO2 maxima
were observed to coincide with the 129Xe-RBC signal
minima, suggestive of a link between pulmonary oxygen-
ation and 129Xe-RBC signal changes. The calculated sO2
of 0.87 for both volunteers at the beginning of the
breath hold suggests that the observed 129Xe-RBC signal
comprises 129Xe dissolved in blood containing RBCs
with mixed sO2 values; otherwise it would be expected
that the calculated sO2 would equal either 1.00 for fully
oxygenated blood or 0.75 for deoxygenated blood.
Indeed, for TR values of 100–800 ms, the observed
129Xe-RBC signal should be constituted primarily by
129Xe nuclei dissolved in blood circulating in the alveo-
lar capillary bed, which contains blood with a range of
sO2 values. Signal contribution from
129Xe dissolved in
blood circulating in the pulmonary arteries (precapillary
blood) is assumed to be negligible as a result of 129Xe
polarization losses incurred during 129Xe transit in the
systemic circulation. Signal from 129Xe in the pulmonary
veins is also considered to be negligible, as the postcapil-
lary 129Xe signal is destroyed by 90 RF pulses for TR
values of 100–800 ms, which are of the order of the RBC
capillary transit time of 750 ms.
A first-order estimate of the expected average sO2 of RBCs
which contribute to the observed 129Xe-RBC signal for TR5
800 ms can be derived using the following assumption: the
average RBC oxygenation in the capillaries sO2c 5 [0.75
(deoxygenated)1 1.00 (oxygenated)] / 25 0.88. This agrees
well with the sO2 value of 0.87 calculated from the 22
ppm chemical shift observed at the start of breath hold
apnea in both healthy volunteers for TR5 800 ms.
After 35 s of breath hold apnea, a decrease in the observed
sO2 of 7–10 % was calculated for both volunteers. During
breath hold the oxygen partial pressure, pO2, in the lungs
will decrease over time. Measurements of changes in oxy-
gen partial pressure as a function of breath hold have been
performed in both animal and human lungs using hyperpo-
larized 3He MR (16,53,54). It was shown in humans that
over short breath holds (< 40 s), the decrease in pO2 can be
approximated by a linear relationship (15,16,53)
pO2ðtÞ5p02Rt [8]
where R is the rate of oxygen extraction by perfusion
and p0 is the initial pO2. Previous studies involving pO2
mapping with 3He in healthy volunteers (16,53,55)
reported R to decrease with decreasing p0. This may be a
result of the lower baseline pO2 reducing the alveolar-
capillary pO2 gradient, and, therefore, decreasing the
rate of diffusion of oxygen from the alveoli into the
capillaries. It is worth noting that over long breath holds
and/or large R values, an exponential model of oxygen
depletion should be used instead of Equation [8], which
for small t is the first term in the Taylor expansion of an
FIG. 7. Correlation of 129Xe-RBC relaxation rate and 129Xe-RBC
chemical shift in whole blood samples over the full (0.06–1.00)
blood oxygenation range.
FIG. 8. In vivo lung blood oxygenation and 129Xe-RBC signal
changes over breath hold apnea measured from two healthy volun-
teers, (a) and (b) (28 and 24 years old, respectively). The blood oxy-
genation and 129Xe-RBC signal oscillate at the same frequency where
the blood oxygenation maxima/minima coincide with 129Xe-RBC
signal minima/maxima (i.e. a phase difference of 180).
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exponential function (54). Assuming a functional resid-
ual capacity of 3 L for the healthy male volunteers in
this study and a resting pO2 of 140 mbar (38), the pO2
drop upon inhalation of 1 L of anoxic gas (Xe/N2) can be
estimated by scaling the pO2 with the increase in lung vol-
ume to 4 L, i.e. p05 1403ð3=4Þ  105 mbar. The R value
for p05 105 mbar has been reported to be R 5 0.7 mbar/s
(55). Inserting these values into Equation [8], the pO2 is
estimated to drop to pO2 5 81 mbar at the end of 35 s of
breath hold apnea, which corresponds to a saturation sO2
value of 0.89 from the standard oxygen-hemoglobin disso-
ciation curve (56,57). Using this value, the average alveolar
capillary bed oxygenation can be calculated as sO2c 5
[0.75 (deoxygenated) 1 0.89 (oxygenated)] / 2 5 0.82,
which is in reasonable agreement with the sO2 estimates
(measured from the 129Xe chemical shift) of approximately
0.80 for both volunteers after 35 s of breath hold apnea.
For TR 5 100 ms, both the 129Xe-RBC and 129Xe-TP
signals were observed to oscillate at a frequency close to
the cardiac pulsation frequency (Figure 9), suggesting that
the lower frequency signal oscillation observed for TR 5
800 ms (Figure 8) is actually an alias of the higher fre-
quency oscillation observed for TR 5 100 ms. The gray
line in Figure 9b shows artificial signal sampling at a rate
of 800 ms21 to illustrate this effect. 129Xe-RBC and 129Xe-
TP signal oscillations at similar cardiac pulsation frequen-
cies were first observed by Venkatesh et al. (58) and have
been more recently observed by Ruppert et al. (59), where
the signal oscillations were attributed to changes in blood
flux into the capillaries within the cardiac cycle.
For the faster-sampled experiment at TR 5 100 ms, the
spectral resolution was limited to 0.7 ppm, which was
insufficient to spectrally discriminate changes in the
129Xe-RBC chemical shift over the breath hold. It is possi-
ble that the observed sO2 for TR 5 100 ms would be lower
than that observed for TR 5 800 ms; for short TRs, the
RBCs have less time to travel through the capillaries into
the pulmonary veins in between RF pulses (i.e. it is possi-
ble that the observable pulmonary sO2 varies as a function
of the TR used). Cardiac-gated acquisitions may allow the
probing of 129Xe-RBC chemical shifts (sO2) at specific time
points in the cardiac cycle, opening up the possibility of
using 129Xe NMR to quantify temporal blood oxygenation
changes in the cardiopulmonary vascular circuit.
With the assumption that the 129Xe-TP signal modula-
tion arises from blood plasma flux changes within the car-
diac cycle, it is possible to compare the peak-to-peak
129Xe-RBC signal, amplitude, SA, with the
129Xe-TP signal
amplitude, SB, to estimate the relative RBC and plasma
concentrations in the blood circulating through the capil-
laries. Thus, by taking the average of the first five SA and
SB values after steady-state was reached, SA5 0:1136
0:004 and SB5 0:05060:003, respectively, the HCT in the
capillaries may be estimated from
HCTc5
x
x11
[9]
where x5SAdB=SBdA and dA5 0.27, dB5 0.094 are the
solubilities of xenon in RBCs and plasma at 37 C (60).
Inserting these values into Equation [9] gives HCTc 5
0.44, in good agreement with the Fa˚hræus effect which
predicts HCT < 0.50 (61) for blood flowing in narrow
vessels such as the pulmonary capillaries. This is poten-
tially of interest clinically; however, further work is
required to validate this technique for measurement of
HCT in the pulmonary capillaries.
This dissolved 129Xe spectroscopy oximetry technique
may also have applications outside of the lungs. For
example, Mazzanti et al. (62) have recently shown that
the signal of 129Xe dissolved in the rat brain can be
modulated in a manner responsive to stimuli, suggestive
that there is a significant contribution to the measured
129Xe signal from blood flow/perfusion. Moreover, dis-
solved 129Xe spectra from the human brain have been
successfully acquired (63), suggesting that 129Xe can be
detected in organs quite distal from the point of uptake
in the lungs.
Finally, this work has implications for Dixon-based
dissolved 129Xe imaging methods (64,65), which rely
upon a fixed chemical shift difference between the target
spectroscopic compartments; the frequency difference
between compartments is encoded as a phase shift in a
given echo time and the different echo times need to be
FIG. 9. a: In vivo 129Xe-RBC signal in the lungs as a function of
breathhold time for a TR of 100 ms, fitted with an exponential
function. b: In vivo 129Xe-RBC and 129Xe-TP signal changes nor-
malized to the fitted exponential in (a). The gray line illustrates the
effect of sampling the observed 129Xe-RBC and 129Xe-TP signal
oscillations at a rate of 800 ms1.
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fixed in value. Therefore, drift in the 129Xe-RBC peak
position would affect the intensity of the 129Xe-RBC
phase image.
CONCLUSIONS
In this study, the feasibility of using hyperpolarized
129Xe as an exogenous NMR probe of pulmonary blood
oxygenation in humans has been explored. A nonlinear
relationship between the measured sO2 values and the
NMR resonance frequency of 129Xe dissolved in RBCs
has been observed in vitro from blood samples at 1.5 T
and 3 T. This relationship was evaluated over the entire
range of possible blood oxygenation values and appears
to be independent of magnetic field strength.
Furthermore, this relation has been used to derive
lung blood sO2 values by means of in vivo dissolved
129Xe whole-lung spectroscopy experiments conducted
during apnea on a 3 T whole body system. To date, we
are not aware of any other means of noninvasively meas-
uring pulmonary blood oxygenation. The common modu-
lation frequency of blood oxygenation and 129Xe-RBC
signal change during breath hold is interesting and fur-
ther work with cardiac-gated hyperpolarized 129Xe NMR
is underway to help understand this newly observed
phenomenon. Lastly, the HCT in the pulmonary capilla-
ries has been estimated from 129Xe spectroscopic data.
Further work is underway to validate hyperpolarized
129Xe NMR as a noninvasive technique for quantification
of HCT in the pulmonary capillaries.
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